Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianbizhi injection for treatment of dengue fever
ChiCTR-IPR-16009233Phase 4Recruiting
- Sponsor
- Fuzhou Mengchao Hepatobiliary Hospital
- Start
- Sep 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of andrographolide sulfonate in dengue fever (2 arms), sponsored by Fuzhou Mengchao Hepatobiliary Hospital. Primary endpoints: Fever relief time and Main symptoms relief time. Started Sep 2016; status: recruiting.
02
Drugs
andrographolide sulfonate
03
Conditions
dengue fever
Beyond the preview
Go deeper on ChiCTR-IPR-16009233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009233.